Stem Cells Market Major Advancements And Future Growth Till 2025
According to a report by Grand View Research, Inc., the stem cell market was valued at USD 8.65 billion in 2018 and is projected to exhibit a healthy CAGR of 8.8% throughout the forecast period (2019-2025). Technological progressions in stem cell manufacturing & preservation and growing public consciousness about the therapeutic potency of the product are likely to drive the market in the forecast period. In addition, rising private-public funding and investment in stem cell-based research and consciousness about the therapeutic effects of stem cell products are anticipated to boost the market throughout the forecast period.
The factors like rising government support for stem cell therapeutics in Europe and U.S. and growth of innovative genomic analysis techniques for quality control in the stem cell production are expected to propel the market. On the other hand, substantial operational prices associated with stem cell manufacturing, banking, and long approval processes are likely to hamper the market growth in the forthcoming period.
In March 2016, scientists at Michigan State University introduced novel type of cells, called induced XEN cells, invented from a cellular trash pile. The decisions drawn from this investigation study is anticipated to propel developing regenerative medicine treatment procedures. In January 2019, research experts at the University of Freiburg performed a research where they repaired damaged organs with the help of potential of mesenchymal stems cells. This is also estimated to increase sales as well as research in the stem cell during the study period.
Asia Pacific is anticipated to record the fastest CAGR over the forthcoming period. Developing countries such as Singapore, Japan, and Australia are investing a lot in the R&D projects, which is set to propel regional development in the years to come. In addition, countries from the Asia Pacific region are projected to be the frontrunners in the stem cell industry in coming years. Favorable regulatory policies, commercialization opportunities will drive the regional expansion in the forecast period.
Leading players operating in the stem cell market include STEMCELL Technologies Inc.; Celgene Corporation; Osiris Therapeutics Inc.; Advanced Cell Technology Inc.; BIOTIME, INC.; Cytori Therapeutics; Human Longevity Inc.; Cynata; Promethera Biosciences; and Mesoblast.
Get More Information At : www.grandviewresearch.com/industry-analysis/stem-cells-market
The factors like rising government support for stem cell therapeutics in Europe and U.S. and growth of innovative genomic analysis techniques for quality control in the stem cell production are expected to propel the market. On the other hand, substantial operational prices associated with stem cell manufacturing, banking, and long approval processes are likely to hamper the market growth in the forthcoming period.
In March 2016, scientists at Michigan State University introduced novel type of cells, called induced XEN cells, invented from a cellular trash pile. The decisions drawn from this investigation study is anticipated to propel developing regenerative medicine treatment procedures. In January 2019, research experts at the University of Freiburg performed a research where they repaired damaged organs with the help of potential of mesenchymal stems cells. This is also estimated to increase sales as well as research in the stem cell during the study period.
Asia Pacific is anticipated to record the fastest CAGR over the forthcoming period. Developing countries such as Singapore, Japan, and Australia are investing a lot in the R&D projects, which is set to propel regional development in the years to come. In addition, countries from the Asia Pacific region are projected to be the frontrunners in the stem cell industry in coming years. Favorable regulatory policies, commercialization opportunities will drive the regional expansion in the forecast period.
Leading players operating in the stem cell market include STEMCELL Technologies Inc.; Celgene Corporation; Osiris Therapeutics Inc.; Advanced Cell Technology Inc.; BIOTIME, INC.; Cytori Therapeutics; Human Longevity Inc.; Cynata; Promethera Biosciences; and Mesoblast.
Get More Information At : www.grandviewresearch.com/industry-analysis/stem-cells-market
Comments
Post a Comment